.png){kind=icon}
.png){kind=icon}
Return
Exploring the Impact of Antimicrobial Resistance on Sustainable Development Goal 3 in Low- and Middle-Income Countries: A Scoping Review
.png){kind=icon}
OA
AI
N
A
DOI：10.1016/j.jgar.2026.05.005.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• AMR threatens SDG 3 goals like UHC, maternal health, and communicable and non-communicable disease treatments in LMICs. • Inequities in healthcare facilities and limited antibiotic access worsens AMR, with the greatest impact in South Asia and sub-Saharan Africa. • Self-medication (7.3–81.3%) slows SDG 3 progress in LMICs more aggressively than in high-income countries. • AMR harms women’s health, raising maternal deaths 19 × higher in LMICs than HICs. • Research on AMR’s SDG 3 impact is limited; full target analysis is still lacking. • Global action is vital: better surveillance, antimicrobial stewardship, improved financing, and trade in health services.is the key to progress with SDG3 in LMICs
Keywords:
Sustainable developmental goals
Antimicrobial resistance
Lower-middle income countries
Antibiotics
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.2
Papers:
2.8K
Citations:
5.7K